NuVasive Announces First Quarter 2017 Financial Results

Go back to NuVasive Announces First Quarter 2017 Financial Results

NuVasive (NUVA) PT Raised to $84 at Canaccord Genuity; Buy the Weakness

April 26, 2017 9:59 AM EDT

Canaccord Genuity raised its price target on NuVasive (NASDAQ: NUVA) to $84.00 (from $82.00) while maintaining a Buy rating following Q1 results, saying shares should be bough on today's weakness.

Analyst Kyle Rose said the company is in prime share-taking position in the global... More

NuVasive (NUVA) Reports In-Line Q1 EPS; Guides Relativity In-Line

April 25, 2017 4:06 PM EDT

NuVasive (NASDAQ: NUVA) reported Q1 EPS of $0.38, in-line with the analyst estimate of $0.38. Revenue for the quarter came in at $250 million versus the consensus estimate of $250.8 million.

"NuVasive is off to a solid start to the year, with our International business exceeding... More